Trial Profile
Safety and Efficacy of G-CSF 'filgrastim BS' administration in the peripheral blood stem cell (PBSC) mobilization
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2020
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Stem cell mobilisation
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2014 New trial record